Fetus-specific CYP3A7 and Adult-specific CYP3A4 Expressed in Chinese Hamster CHL Cells Have Similar Capacity to Activate Carcinogenic Mycotoxins

Cancer Research

Volumn 55, Issue 4, 1995, Pages 787-791

  Hashimoto, Hisashi ^a   Nakagawa, Tetsuya ^a   Yokoi, Tsuyoshi ^a   Sawada, Minora ^a   Itoh, Susumu ^a,b   Kamataki, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; AFLATOXIN G1; ALPHA NAPHTHOFLAVONE; COMPLEMENTARY DNA; CYTOCHROME P450 ISOENZYME; LIVER ENZYME; MESSENGER RNA; MYCOTOXIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; STERIGMATOCYSTIN; TROLEANDOMYCIN;

AGE; ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL SURVIVAL; CELL TRANSFORMATION; CHINESE HAMSTER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL; NONHUMAN; PRIORITY JOURNAL;

ADULT; AFLATOXIN B1; AGING; ANIMAL; BENZOFLAVONES; BIOTRANSFORMATION; CARCINOGENS; CELL LINE; CLONE CELLS; COMPARATIVE STUDY; CRICETULUS; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; DRUG INTERACTIONS; FETUS; GENE EXPRESSION; GUINEA PIGS; HAMSTERS; HUMAN; MYCOTOXINS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TRANSFORMATION, GENETIC; TROLEANDOMYCIN;

EID: 0028888384     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Nelson, D. R., Kamataki, T., Waxman, D. J., Gucngcrich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O., Okada, K., and Nebert, W. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol., 12: 1–51, 1993.
2. Watkins, P. B., Wrighton, S. A., Maurel, P., Schuetz, E. G., Mendez-Picon, G., Parker, G. A., and Guzelian, P. S. Identification of an inducible form of cytochrome P-450 in human liver. Proc. Natl. Acad. Sci. USA, 82: 6310–6314, 1985.
3. Molowa, D. T., Schetz, E. G., Wrighton, S. A., Watkins, P. B., Kremers, P., Mendez-Picon, G., Parker, G. H., and Guzelian, P. S. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc. Natl. Acad. Sci. USA, 83: 5311–5315, 1986.
4. Beaune, P. H., Umbcnhaucr, D. R., Bork, R. W., Lloyd, R. S., and Gucngcrich, F. P. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine-oxidase. Proc. Natl. Acad. Sci. USA, 83: 8064–8068, 1986.
5. Gonzalez, F. J., Schmid, B. J., Umeno, M., Mcbride, O. W., Hardwick, J. P., Meyer, U. A., Gelboin, H. V., and Idle, J. R. Sequence, chromosome localization and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA, 7: 79–86, 1988.
6. Bork, R. W., Muto, T., Beaune, P. H., Srivastava, P. K., Lloyd, R. S., and Guengerich, F. P. Characterization of raRNA species related to human liver cytochrome P-450 nifedipine oxidase and regulation of catalytic activity. J. Biol. Chem., 246: 910–919, 1989.
7. Aoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. P., Mayer, U. A., Fischer, V., Tyndale, R., Inaba, T., Kalow, W., Gelboin, H. V., and Gonzalez, F. J. Cytochrome P-450 hPCN3, a novel cytochrome P-450IIIA gene product that is differently expressed in adult human liver. J. Biol. Chem., 264: 10388–10395, 1989.
8. Schuetz, J. D., Molowa, D. T., and Guzelian, P. S. Characterization of cDNA encoding a new number of the glucocorticoid-responsive cytochrome P450 in human liver. Arch. Biochem. Biophys., 274: 355–365, 1989.
9. Komori, M., Nishio, K., Fujitani, T., Ohi, H., Kitada, M., Mima, S., Itahashi, K., and Kamataki, T. Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch. Biochem. Biophys., 272: 219–225, 1989.
10. Komori, M., Nishio, K., Ohi, H., Kitada, M., and Kamataki, T. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P450. J. Biochem., 105: 161–163, 1989.
11. Komori, M., Nishio, K., Kitada, M., Shiramatsu, K., Muroya, K., Soma, M., Nagashima, K., and Kamataki, T. Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry, 29: 4430–4433, 1990.
12. Hashimoto, H., Toide, K., Kitamura, R., Fujita, M., Tagawa, S., Itoh, S., and Kamataki, T. Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. Eur. J. Biochem., 218: 585–595, 1993.
13. Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., and Waxman, D. J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genomic polymorphism in oxidative drug metabolism. J. Biol. Chem., 261: 5051–5060, 1986.
14. Shimada, T., Iwasaki, M., Martin, M. V., and Guengerich, F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcino-gens detected by umu gene response in Salmonella typhimurium TA 1535/pSK10β2. Cancer Res., 49: 3218–3228, 1989.
15. Shimada, T., and Guengerich, F. P. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci. USA, 86: 462–465, 1989.
16. Doehmer, J., Dogra, S., Friedberg, T., Monier, S., Adesinik, M., Glatt H., and Oesch, F. Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin Bl. Proc. Natl. Acad. Sci. USA, 85: 5769–5773, 1988.
17. Crespi, C. L., Langenbach, R., Rudo, K., Chen, Y-T., and Davies, R. L. Transfection of a human cytochrome P-450 gene into the human lymphoblastoid cell line, AHH-1, and use of the recombinant cell line in gene mutation assays. Carcinogenesis (Lond.), 10: 295–301, 1989.
18. Davies, R. L., Crespi, C. L., Rudo, K., Turner, T. R., and Langenbach, R. Development of a human cell line by selection and drug-metabolizing gene transfection with increased capacity to activate promutagens. Carcinogenesis (Lond.), 10: 885–891, 1989.
19. Crespi, C. L., Steimel, D. T., Aoyama, T., Gelboin, H. V., and Gonzalez, F. J. Stable expression of human cytochrome P450LA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B,. Mol. Carcinog., 3: 5–8, 1990.
20. Dogra, S., Doehmer, J., Glatt, H., Molders, H., Siegert, P., Friedberg, T., Seidel, A., and Oesch, F. Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing. Mol. Pharmacol., 37: 608–613, 1990.
21. Schmalix, W. A., Maser, H., Kiefer, F., Reen, R., Wiebel, F., Gonzalez, F. J., Seidel, A., Glatt, H., and Doehmer, J. Stable expression of human cytochrome P4501A1 cDNA in V79 Chinese hamster cells and metabolic activation of benzo[a]pyrene. Eur. J. Pharmacol., 248: 251–261, 1993.
22. Itoh, S., Tagawa, S., Sawada, M., and Kamataki, T. High susceptibility to aflatoxin B, and benzo[a]pyrene of BALB3T3 A31–1–1 cells expressing monkey CYP1A1. J. Toxicol. Sci., 18: 207–210, 1993.
23. Sawada, M., Kitamura, R., and Kamataki, T. Stable expression of monkey cytochrome P-450LA1 cDNA in Chinese hamster CHL cells and its application for detection of mutagenicity of aflatoxin B1. Mutat. Res., 265: 23–29, 1992.
24. Sawada, M., Kitamura, R., Ohgiya, S., and Kamataki, T. Stable expression of mouse NADPH-cytochrome P450 reductase and monkey P4501A1 cDNAs in Chinese hamster cells: establishment of cell lines highly sensitive to aflatoxin B,. Arch. Biochem. Biophys., 300: 164–168, 1993 (Erratum, 310: 289, 1994).
25. Yanagimoto, T., Itoh, S., Sawada, M., Hashimoto, H., and Kamataki, T. Molecular cloning and functional expression of mouse cytochrome P-450 (Cyp3a-13): examination of Cyp3a-13 enzyme to activate aflatoxin B,(AFB,). Biochim. Biophys. Acta, 1201: 405–410, 1994.
26. Yanagawa, Y., Sawada, M., Deguchi, T., Gonzalez, F. J., and Kamataki, T. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-dimethylimidazo(4,5-f) Jquinoline and 2-amino-3,8-dimemylimidazo[4,5-f]quinoxaline (MelQx). Cancer Res., 54: 3422–3427, 1994.
27. Funae, Y., and Imaoka, S. Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. Biochem. Biophys. Acta, 842: 119–132, 1985.
28. Itoh, S., Yanagimoto, T., Tagawa, S., Hashimoto, H., Kitamura, R., Nakajima, Y., Okochi, T., Fujimoto, S., Uchino, J., and Kamataki, T. Genomic organization of human fetal specific P-450IIIA7 (cytochrome P-450HFLa)-related gene(s) and interaction of transcriptional regulatory factor with its DNA element in 5′ flanking region. Biochim. Biophys. Acta, 1130: 133–138, 1992.
29. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Coning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
30. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156–159, 1987.
31. Sakuma, T., Masaki, K., Itoh, S., Yokoi, T., and Kamataki, T. Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs. Mol. Pharmacol., 45: 228–236, 1993.
32. Schwab, G. E., Raucy, J. L., and Johnson, E. F. Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by a-naphthoflavone. Mol. Pharmacol., 33: 493–499, 1988.
33. Tinel, M., Descatoire, V., Larrey, D., Loeper, J., Labbe, G., Letteron, P., and Pessayre, D. Effects of clarithromycin on cytochrome P-450: comparison with other macrolides. J. Pharmacol. Exp. Ther., 250: 746–751, 1989.
34. Halpert, J. R., Guengerich, F. P., Bend, J. R., and COrreia, M. A. Selective inhibitors on cytochromes P450. Toxicol. Appl. Pharmacol., 125: 163–175, 1994.
35. Sofuni, T., Matsuoka, A., Sawada, M., Ishidate, M., Jr., Zeiger, E., and Shelby, M. D. A comparison of chromosome aberration induction by 25 compounds tested by two Chinese hamster cell (CHL and CHO) systems in culture. Mutat. Res., 241: 175–213, 1990.
36. Wiebel, J. F., Lambiotte, M., Singh, J., Summer, K-H., and Wolff, T. Biochemical Bases of Chemical Carcinogenesis, pp. 77–88. NY: Raven Press, 1984.
37. Glatt, H., Gemperlein, I., Setiabudi, F., Piatt, K. L., and Oesch, F. Expression of xenobiotic-metabolizing enzymes in propagatable cell culture and induction of micronuclei by 13 compounds. Mutagenesis, 5: 241–249, 1990.
38. Kitada, M., Taneda, M., Ohi, H., Komori, M., Itahashi, K., Nagao, M., and Kamataki, T. Mutagenic activation of aflatoxin B, by P-450 HFLa in human fetal livers. Mutat. Res., 227: 53–58, 1989.
39. Aoyama, T., Yamano, S., Guzelian, P. S., Gelboin, H. V., and Gonzalez, F. J. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proc. Natl. Acad. Sci. USA, 87: 4790–4793, 1990.
40. Crespi, C. L., Penman, B. W., Steimel, D. T., Gelboin, H. V., and Gonzalez, F. J. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B, and comparison to CYP1A2 and CYP2A3. Carcinogenesis (Lond.), 12: 355–359, 1991.
41. Kitada, M., Taneda, M., Ohta, K., Nagashima, K., Itahashi, K., and Kamataki, T. Metabolic activation of aflatoxin Bt and 2-amino3-methylimidazo[4,5-b]quinoline by human adult and fetal livers. Cancer Res., 50: 2641–2645, 1990.
42. Wrighton, S. A., and Stevens, J. C. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol., 22: 1–21, 1992.
43. Kitada, M., Kamataki, T., Itahashi, K., Rikihisa, T., Kato, R., and Kanakubo, Y. Purification and properties of cytochrome P-450 from homogenates of human fetal livers. Arch. Biochem. Biophys., 241: 275–280, 1985.